Lista de obras - Takashi Onda - Dominio Público Uruguay

A case of vaginal clear cell adenocarcinoma complicated with congenital anomalies of the genitourinary tract and metanephric remnant without prenatal diethylstilbestrol exposure

artículo científico publicado en 2010

A rare case of recurrent ovarian cancer presenting as a round ligament metastasis

artículo científico publicado en 2011

Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsy

artículo científico publicado en 1996

Assessment of transposed ovarian movement: how much of a safety margin should be added during pelvic radiotherapy?

artículo científico publicado en 2015

Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA.

artículo científico publicado en 1993

Bifunctional roles of survivin-ΔEx3 and survivin-2B for susceptibility to apoptosis in endometrial carcinomas

artículo científico publicado en 2014

CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker

scientific article published on 01 January 2003

Characterization of IgA response among women with incident HPV 16 infection

artículo científico publicado en 2003

Cisplatin, paclitaxel and escalating doses of doxorubicin (TAP) in advanced ovarian cancer: a phase I trial

scientific article published on 01 September 2004

Clinical aspects and prognosis of pelvic recurrence of cervical carcinoma

scientific article published on 01 April 2005

Clinical characteristics and outcomes of women with stage IV endometrial cancer.

artículo científico publicado en 2009

Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).

artículo científico

Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma.

artículo científico publicado en 2012

Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix.

artículo científico publicado en 2012

Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial

scientific article published on 13 March 2020

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncol

artículo científico publicado en 2016

Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas

artículo científico publicado en 2002

Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity.

artículo científico publicado en 2015

Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma acuminata.

artículo científico publicado en 2003

Familial risk factors for a second primary malignancy in endometrial or ovarian carcinoma

scientific article published on 01 June 1995

Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206

artículo científico publicado en 2004

Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206

artículo científico publicado en 2009

Independent association of antibodies against human papillomavirus type 16 E1/E4 and E7 proteins with cervical cancer

artículo científico publicado el 1 de octubre de 1992

Minimization of curative surgery for treatment of early cervical cancer: a review

artículo científico

Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions ⬇️

artículo científico publicado el 1 de julio de 2011

Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101)

artículo científico publicado en 2014

Novel virtual cytological analysis for the detection of endometrial cancer cells using autoscan fluoromicroscopy ⬇️

artículo científico publicado el 7 de marzo de 2011

Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives

artículo científico publicado en 2015

Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602

artículo científico publicado en 2008

Prevalence of ovarian endometriosis in epithelial ovarian cancer

scientific article published on 01 December 1997

Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.

artículo científico publicado en 2017

Prognostic impact of the history of breast cancer and of hormone therapy in uterine carcinosarcoma.

artículo científico publicado en 2012

Prognostic significance of positive peritoneal cytology in adenocarcinoma of the uterine cervix

artículo científico publicado en 2009

Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix.

scientific article published on May 2009

Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.

artículo científico publicado en 2009

Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection.

artículo científico publicado en 2005

Serous adenocarcinoma of the uterine cervix: a clinicopathological study of 12 cases and a review of the literature.

artículo científico publicado en 2011

Surgical treatment for neuroendocrine carcinoma of the uterine cervix

artículo científico publicado en 2007

The history of the Gynecologic Cancer Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG).

artículo científico

The optimal debulking after neoadjuvant chemotherapy in ovarian cancer: proposal based on interval look during upfront surgery setting treatment

artículo científico publicado en 2009

Versatile lotus petal flap for vulvoperineal reconstruction after gynecological ablative surgery.

artículo científico publicado en 2004

Lista de obras de Takashi Onda

A case of vaginal clear cell adenocarcinoma complicated with congenital anomalies of the genitourinary tract and metanephric remnant without prenatal diethylstilbestrol exposure

A rare case of recurrent ovarian cancer presenting as a round ligament metastasis

Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsy

Assessment of transposed ovarian movement: how much of a safety margin should be added during pelvic radiotherapy?

Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA.

Bifunctional roles of survivin-ΔEx3 and survivin-2B for susceptibility to apoptosis in endometrial carcinomas

CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker

Characterization of IgA response among women with incident HPV 16 infection

Cisplatin, paclitaxel and escalating doses of doxorubicin (TAP) in advanced ovarian cancer: a phase I trial

Clinical aspects and prognosis of pelvic recurrence of cervical carcinoma

Clinical characteristics and outcomes of women with stage IV endometrial cancer.

Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).

Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma.

Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix.

Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncol

Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas

Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity.

Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma acuminata.

Familial risk factors for a second primary malignancy in endometrial or ovarian carcinoma

Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206

Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206

Independent association of antibodies against human papillomavirus type 16 E1/E4 and E7 proteins with cervical cancer

Minimization of curative surgery for treatment of early cervical cancer: a review

Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions ⬇️

Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101)

Novel virtual cytological analysis for the detection of endometrial cancer cells using autoscan fluoromicroscopy ⬇️

Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives

Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602

Prevalence of ovarian endometriosis in epithelial ovarian cancer

Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.

Prognostic impact of the history of breast cancer and of hormone therapy in uterine carcinosarcoma.

Prognostic significance of positive peritoneal cytology in adenocarcinoma of the uterine cervix

Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix.

Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.

Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection.

Serous adenocarcinoma of the uterine cervix: a clinicopathological study of 12 cases and a review of the literature.

Surgical treatment for neuroendocrine carcinoma of the uterine cervix

The history of the Gynecologic Cancer Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG).

The optimal debulking after neoadjuvant chemotherapy in ovarian cancer: proposal based on interval look during upfront surgery setting treatment

Versatile lotus petal flap for vulvoperineal reconstruction after gynecological ablative surgery.